|
Genedx Holdings Corp (NASDAQ: WGS) |
|
|
|
Genedx Holdings 's Revenue per Employee
Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales
With a revenue increase of 44.26% in the third quarter 2024, year on year to cumulative value of $267 million, Genedx Holdings 's revenue per employee grew on a trailing twelve months basis to $ 1,335,215. The productivity of Genedx Holdings 's employees was 5.7795234309164E-11%, above the company average. Within the Healthcare sector Employees of 61 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 556, from total ranking in previous quarter at 575. Genedx Holdings has 200 employees.
What is Sales per Employee Ratio?
Select the Comparisons :
|
|
Select the Ratio:
|
|
WGS Revenue per Employee |
(Sep 30 2024) III. Quarter |
(Jun 30 2024) II. Quarter |
(Mar 31 2024) I. Quarter |
(Dec 31 2023) IV. Quarter |
(Sep 30 2023) III. Quarter |
Y / Y Revenue Change |
44.26 % |
46.47 % |
44.67 % |
- |
-36.01 % |
Sales per Employee
(TTM) $ |
1,335,215 |
1,217,365 |
1,106,390 |
1,010,030 |
720,775 |
WGS's Total
Ranking |
# 556 |
# 575 |
# 0 |
# 0 |
# 0 |
Seq. Revenue Change |
9.83 % |
12.08 % |
7.88 % |
8.62 % |
11.52 % |
Revenue per Employee Statistics |
High |
Average |
Low |
$ 1,711,805 |
$ 1,315,388 |
$ 1,010,030 |
(Sep 30 2022) |
|
(Dec 31 2023) |
Date modified: 2024-10-29T21:55:46+00:00
Companies with similar Revenue per Employee for 12 months ending Sep 30 2024, within Healthcare Sector | Revenue per Employee | Revenue 12 months ending Sep 30 2024 | Number of Employees Sep 30 2024 | Puma Biotechnology Inc | 2,230,460.78 | $ 227.507 Million | 102 | Inspire Medical Systems inc | 2,134,283.29 | $ 753.402 Million | 353 | Sanuwave Health Inc | 2,095,823.53 | $ 35.629 Million | 17 | Biocryst Pharmaceuticals Inc | 2,094,309.64 | $ 412.579 Million | 197 | Transmedics Group Inc | 2,005,450.00 | $ 401.090 Million | 200 | Vertex Pharmaceuticals Inc | 1,967,740.74 | $ 10,625.800 Million | 5,400 | Fortrea Holdings Inc | 1,966,111.11 | $ 3,539.000 Million | 1,800 | Prestige Consumer Healthcare Inc | 1,947,647.37 | $ 1,110.159 Million | 570 | Castle Biosciences Inc | 1,901,695.12 | $ 311.878 Million | 164 | American Shared Hospital Services | 1,889,090.91 | $ 20.780 Million | 11 | Semler Scientific inc | 1,841,781.25 | $ 58.937 Million | 32 | Beam Therapeutics Inc | 1,840,226.32 | $ 349.643 Million | 190 | Sunshine Biopharma Inc | 1,831,082.89 | $ 32.959 Million | 18 | Spero Therapeutics Inc | 1,804,338.98 | $ 106.456 Million | 59 | Assertio Holdings inc | 1,796,614.29 | $ 125.763 Million | 70 | Lantheus Holdings Inc | 1,793,589.93 | $ 1,495.854 Million | 834 | Corcept Therapeutics Inc | 1,785,667.61 | $ 628.555 Million | 352 | Rockwell Medical inc | 1,768,839.29 | $ 99.055 Million | 56 | Amylyx Pharmaceuticals Inc | 1,738,805.31 | $ 196.485 Million | 113 | The Beauty Health Company | 1,737,310.00 | $ 347.462 Million | 200 | Paragon 28 inc | 1,688,701.39 | $ 243.173 Million | 144 | Krystal Biotech Inc | 1,665,641.38 | $ 241.518 Million | 145 | Xoma Royalty Corporation | 1,662,000.00 | $ 21.606 Million | 13 | Geron Corp | 1,637,777.78 | $ 29.480 Million | 18 | Verve Therapeutics Inc | 1,626,400.00 | $ 24.396 Million | 15 | Zomedica Corp | 1,622,812.50 | $ 25.965 Million | 16 | Incyte Corporation | 1,614,841.52 | $ 4,075.860 Million | 2,524 | Neurocrine Biosciences Inc | 1,602,000.00 | $ 2,242.800 Million | 1,400 | Ufp Technologies Inc | 1,585,220.69 | $ 459.714 Million | 290 | Gilead Sciences Inc | 1,572,166.67 | $ 28,299.000 Million | 18,000 |
|